European citizen Pharmacogenomics
novel health
health outcome
Ubiquitous Pharmacogenomics
existing pharmacogenomics guidelines
clinical implementation of pharmacogenomics
existing European health care environments
European strategies
health system organisations
multiple pharmacogenomic variants
panel of important pharmacogenomic variants
actionable pharmacogenomic data
U-PGx consortium
personalized medicine
cost-effective drug therapy
new model of personalised medicine
effective treatment optimization accessible
accounts
diversity
study of genetic variability
reduction
trial
large scale
pre-emptive genotyping approach
individual’s response
error
settings
solutions
patients’ electronic record
use
Feasibility
cost-effectiveness
findings
goal
project